HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

GLU298ASP and 4G/5G Polymorphisms and the Risk of Ischemic Stroke in Young Individuals.

AbstractBACKGROUND:
Polymorphisms in the endothelial nitric oxide synthase (eNOS) and in the plasminogen activator inhibitor -1 (PAI-1) genes have been implicated in stroke pathogenesis but results are still controversial. The aim of this study was to examine the possible contribution of Glu298Asp in the eNOS and 4G/5G in the PAI-1polymorphisms with ischemic stroke in a young Mexican population.
MATERIALS AND METHODS:
In a case-control study, conducted between January 2006 and June 2010, 204 patients ≤45 years of age with ischemic stroke and 204 controls matched by age and gender, were recruited. The Glu298Asp and 4G/5G polymorphisms were determined in all participants by polymerase chain reaction-restriction fragment length polymorphism.
RESULTS:
There was a significant difference in the Glu298Asp genotype distribution (P=0.001) and allele frequency between the two groups (P=0.001). The 4G/5G genotype distribution (P=0.40) and the allele frequency was similar between groups; (P=0.13). There were independent factors for ischemic stroke: Asp carriage (GluAsp+AspAsp) (P=0.02); smoking (P=0.01); hypertension (P=0.03), and familial history of atherothrombotic disease (P=0.04).
CONCLUSIONS:
The Asp allele from the Gu298Asp gene represents an independent risk factor for ischemic stroke in a young Mexican population. In contrast, the 4G/5G was not associated with an increased risk for this disease in the same group of patients, as previously has been demonstrated in other populations.
AuthorsJuan Carlos Esparza-García, David Santiago-Germán, María Guadalupe Valades-Mejía, Jesus Hernández-Juárez, Eberth Aguilar-Sosa, Alfredo Leaños-Miranda, Antonio Alvarado-Moreno, Abraham Majluf-Cruz, Irma Isordia-Salas
JournalThe Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques (Can J Neurol Sci) Vol. 42 Issue 5 Pg. 310-6 (Sep 2015) ISSN: 0317-1671 [Print] England
PMID26036781 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Plasminogen Activator Inhibitor 1
  • Aspartic Acid
  • Glutamic Acid
  • Nitric Oxide Synthase Type III
Topics
  • Adult
  • Aspartic Acid (genetics)
  • Brain Ischemia (complications)
  • Case-Control Studies
  • DNA Mutational Analysis
  • Female
  • Gene Frequency
  • Genetic Predisposition to Disease (genetics)
  • Genotype
  • Glutamic Acid (genetics)
  • Humans
  • Male
  • Mexico
  • Nitric Oxide Synthase Type III (genetics)
  • Plasminogen Activator Inhibitor 1 (genetics)
  • Polymorphism, Genetic (genetics)
  • Stroke (etiology, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: